DMAC - DiaMedica Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

50.45M

Cash

28.66M

Avg Qtr Burn

-3.178M

Short % of Float

0.36%

Insider Ownership

27.99%

Institutional Own.

18.49%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DM199 (KLK1 protein) Details Heart disease, Ischemic stroke	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DM199 (KLK1 protein) Details Chronic inflammatory disorder, Inflammatory disease, Kidney disease, IgA nephropathy, Chronic kidney disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.